IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype

Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities

(2008) Joshua Z Press et al.   BMC CANCER

External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinoma

(2008) Nathan E. Hoffmann et al.   CANCER

Oncofetal protein IMP3

(2008) Zhong Jiang et al.   CANCER

IMP3 Predicts Aggressive Superficial Urothelial Carcinoma of the Bladder

(2008) L. Sitnikova et al.   CLINICAL CANCER RESEARCH

DNA methylation changes in ovarian cancer: Implications for early diagnosis, prognosis and treatment

(2008) Caroline A. Barton et al.   GYNECOLOGIC ONCOLOGY

Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma

(2008) C. Blake Gilks et al.   HUMAN PATHOLOGY